We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Robotic-assisted gait training in neurological patients: who may benefit?
Annals of Biomedical Engineering 2015 May
Regaining one's ability to walk is of great importance for neurological patients and is a major goal of all rehabilitation programs. Gait training of severely affected patients after the neurological event is technically difficult because of their motor weakness and balance disturbances. An innovative locomotor training that incorporates high repetitions of task-oriented practice by the use of body weight-supported treadmill training (BWSTT) was developed to overcome these obstacles. To facilitate the delivery of BWSTT, a motorized robotic driven gait orthosis (robotic-assisted gait training-RAGT) was developed. Two types of robotic gait devices were developed, end-effector and exoskeleton devices. Several randomized controlled trials have been published regarding the usage of RAGT in patients after stroke, spinal cord injury (SCI), multiple sclerosis (MS) and other neurological diseases. According to these trials, the usage of RAGT in combination with conventional rehabilitation treatment has some additive beneficial effect on the ambulation abilities mainly in sub-acute stroke and sub-acute SCI patients. No difference was found between the two types of robotic gait devices. No sufficient data regarding an optimal protocol of RAGT is available, however a longer duration and a higher intensity of RAGT seem to have more beneficial effect on the final functional ambulation outcomes. Larger controlled studies are still required to determine the optimal timing and protocol design for the maximal efficacy and long-term outcome of RAGT in neurological patients.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app